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ABSTRACT
IRE1a is an endoplasmic reticulum (ER)-located
transmembrane RNase that plays a central role in
the ER stress response. Upon ER stress, IRE1a is
activated and cleaves specific exon–intron sites in
the mRNA encoding the transcription factor X-box-
binding protein 1 (XBP1). In addition, previous
studies allow us to predict that IRE1a targets
several RNAs other than the XBP1. In fact, we
have identified CD59 mRNA as a cleavage target of
IRE1a. However, it is not yet clear how IRE1a recog-
nizes and cleaves target RNAs. To address this
question, we devised a unique method that
combines an in vitro cleavage assay with an exon
microarray analysis, and performed genome-wide
screening for IRE1a cleavage targets. We identified
13 novel mRNAs as candidate IRE1a cleavage
targets. Moreover, an analysis of the novel
cleavage sites revealed a consensus sequence (CU
GCAG) which, when accompanied by a stem-loop
structure, is essential for IRE1a-mediated
cleavage. The sequence and structure were also
conserved in the known IRE1a cleavage targets,
CD59 and XBP1. These findings provide the import-
ant clue to understanding the molecular mecha-
nisms by which IRE1a recognizes and cleaves
target RNAs.
INTRODUCTION
IRE1 is a transmembrane-RNase with an endoplasmic re-
ticulum (ER) luminal sensor domain and cytosolic kinase
and ribonuclease domains (1,2). IRE1 plays a central role
in the ER stress response (3). Upon ER stress, IRE1 is
activated and cleaves speciﬁc mRNAs. In yeast, the
activated Ire1 cleaves the Hac1 mRNA at two sites,
which are then rejoined by the tRNA ligase Rlg1 (4).
These reactions convert the Hac1 mRNA into its mature
form and allow the eﬃcient translation of the Hac1
protein, which functions as a transcription factor that rec-
ognizes the UPR element, located in the upstream regions
of target genes (5,6). In mammals, there are two IRE1
paralogues, IRE1a and IRE1b (7–9). IRE1a is expressed
ubiquitously throughout the body, while the expression of
IRE1b is restricted to the epithelium of the gastrointes-
tinal tract (10). Similar to the yeast Ire1, mammalian
IRE1a is also activated upon ER stress (11,12), and
cleaves speciﬁc exon–intron sites in the mRNA that
encodes the transcription factor X-box-binding protein 1
(XBP1) (13,14). This cleavage initiates an unconventional
splicing reaction, which leads to production of an active
transcription factor and induction of various adaptive
genes.
IRE1a-mediated RNA processing has been studied
most extensively using XBP1. The unconventional
splicing of XBP1 mRNA occurs in the cytoplasm, while
most mRNA splicing occurs in the nucleus (15,16). It was
recently reported that the XBP1 mRNA is tethered to the
cytosolic side of the ER membrane via nascent peptides,
and that this tethering is important for eﬀective processing
(17). Moreover, we found that the region corresponding to
nucleotides (nts) 506–579 of the XBP1 mRNA is necessary
and suﬃcient for XBP1-splicing, and that cleavage and
ligation occur as a coupled reaction (18).
The sole output of activated yeast Ire1 appears to be the
splicing of the Hac1 mRNA (19). However, several studies
have suggested that IRE1 in metazoans has additional
functions not mediated by XBP1 (20,21). Indeed, it was
reported that IRE1a targets a speciﬁc subset of mRNAs in
ﬂies (22), and in mammals, IRE1a cleaves its own mRNA
in addition to XBP1 (23). We found that the human CD59
mRNA is also cleaved by IRE1a, and attenuated in a
stress-dependent manner (24). Moreover, recent studies
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in mammals (25,26), including the insulin mRNA (27).
Meanwhile, IRE1b can cleave the 28S ribosomal RNA
to induce translational repression (9), or the MTP
mRNA to regulate chylomicron production in the intes-
tines (28). Although post-transcriptional gene regulation
mediated by the IRE1 proteins has received a lot of atten-
tion in recent years, it has not been fully elucidated how
these proteins recognize and cleave their targets.
In this study, we devised a novel genome-wide screening
method by combining an in vitro cleavage assay (18,24)
with micro-array analysis. By this approach, we identiﬁed
13 novel targets that were cleaved in vitro by IRE1a.A n
analysis of the cleavage sites revealed a consensus
sequence (CUGCAG) accompanied by a stem-loop struc-
ture. The sequence and structure were also conserved in
the known cleavage targets, CD59 and XBP1. Our results
provide the important clue toward an understanding of
the molecular mechanisms by which IRE1a recognizes
and cleaves its target RNAs.
MATERIALS AND METHODS
Cell culture, transfection and treatment
HeLa cells and HEK293T cells were cultured at 37 Ci n
DMEM supplemented with 100 U/ml penicillin, 100mg/ml
streptomycin and 10% fetal bovine serum, in an atmos-
phere containing 5% CO2. The calcium phosphate–DNA
precipitation method was used to introduce plasmid DNA
into the cells. To induce ER stress, cells were treated with
tunicamycin (2.5mg/ml) for the indicated times
(Supplementary Figure S7).
Northern blot analysis
ISOGEN (Nippon Gene) was used to prepare total RNA
and IRE1a-cleaved RNA fragments. RNAs were loaded
on 1% denaturing agarose gels and transferred onto
Hybond-N membranes (Amersham-Pharmacia).
Hybridization was performed at 65 C in Church buﬀer.
After three washes in Church buﬀer, signals were detected
using the BAS 2500 system (Fuji Film). The following
probes were used to detect XBP1, BiP and CD59:
XBP1, +4 to +493; BiP, +1 to +1959; and CD59,  97
to +486 relative to the ATG. Information about the
other probes used to detect cleavage candidates
(Figure 2A; Supplementary Figures S2, S4 and S7) is
given in Supplementary Table S2. These probes were
radio labeled using the Random Primer DNA Labeling
Kit version 2.0 (Takara).
RNA cleavage assay
In vitro cleavage reactions were performed as described
previously (18,24). Brieﬂy, the cytoplasmic domain of
human IRE1a was expressed in HEK293T cells and
immunoprecipitated with an anti-Flag antibody. For the
preparation of full-length IRE1a (Supplementary
Figure S6), IRE1a-HA (12) was expressed and
immunoprecipitated with an anti-HA antibody. The sub-
strate RNA was incubated with the IRE1a preparation at
37 C, then the resulting fragments were puriﬁed using
ISOGEN (Nippon Gene). The substrates were total
RNA from HEK293T cells (Figures 1B and 2A;
Supplementary Figures S2 and S4), or in vitro transcribed
RNA fragments (Figure 2B; Supplementary Figures S3
and S5). To prepare the RNA fragments, cDNA frag-
ments were subcloned into pBlueScript II SK ( ), and
transcribed using the Riboprobe in vitro Transcription
System (Promega), with the T7 primer. Information
Figure 1. Scheme of the screening approach used to identify cleavage
targets of IRE1a.( A) Schematic representation of the screening pro-
cedure. Cellular RNAs were subjected to in vitro cleavage by the cyto-
plasmic domain of human IRE1a, or by GFP as a mock treatment.
Then the RNAs were reverse transcribed with oligo-dT primers and
treated with RNase H. The resulting RNA fragments, corresponding
to the 50 sides of the cleaved RNAs (represented by the gray bar in the
ﬁgure), were puriﬁed and used as probes in the exon microarray
analysis. (B) Eﬃcient cleavage and production of a probe fragment in
the case of the XBP1 mRNA. Left panel: total RNA (5mg) was
incubated with IRE1a or GFP and analyzed by northern blotting
with a probe speciﬁc for the 50 fragment of the XBP1 mRNA. Right
panel: the RNA samples, as described for the left panel, were reverse
transcribed and treated with RNaseH before blotting.
6266 Nucleic Acids Research, 2010,Vol.38, No. 18Figure 2. IRE1a-dependent cleavage of novel candidates. (A) Production of faster migrating species by treatment with IRE1a. Total RNAs (5mg)
were treated with IRE1a or GFP and analyzed by northern blotting with probes speciﬁc for each cleavage candidate (Supplementary Table S2).
Below each northern blot is a photograph of the stained gel containing the 28S rRNA. The northern blot with the XBP1 probe (50 exon) is included
as a control. (B) In vitro cleavage of the newly identiﬁed IRE1a targets. RNA fragments derived from each candidate mRNA were incubated with or
without IRE1a, resolved on a 2% denaturing agarose gel, and stained with ethidium bromide. A partial fragment of XBP1 was used as a control.
The mRNA region corresponding to each fragment is indicated above the panels.
Nucleic Acids Research, 2010,Vol.38, No. 18 6267about the cloned cDNAs is given in Supplementary
Table S4. In the cleavage reaction with total RNAs,
mock-treated reference sample was prepared using identi-
cal reaction conditions, except that IRE1a was substituted
with GFP. The resulting RNA samples were resolved
on 2% denaturing agarose gels for Figure 2B and
Supplementary Figure S3, or 6% TBE-Urea gels (Novex
TBE-Urea Gels; Invitrogen) for Supplementary Figure S5,
and stained with ethidium bromide. The XBP1 RNA
fragment (266–602) was used as a control (18). An RNA
ladder (100–2000bp; Invitrogen) was used as size marker.
Screening procedure
The screen illustrated in Figure 1A was performed, with
details as follows. Total RNAs (5mg) from HEK293T cells
were subjected to the in vitro cleavage assay using either
the cytoplasmic domain of human IRE1a or GFP. Then
the RNAs were puriﬁed using ISOGEN, reverse
transcribed using an oligo-dT primer and the Superscript
First-Strand Synthesis System (Invitrogen), and treated
with RNase H. The resulting RNA fragments were
puriﬁed using ISOGEN and subjected to the Exon micro-
array analysis. Samples were prepared for the Exon micro-
arrays as follows. The RNA samples were treated with
RiboMinus (Invitrogen) to remove rRNA, and then
reverse-transcribed with random primers to produce
cDNAs. Then the cDNAs were in vitro transcribed to syn-
thesize cRNAs. Finally, ssDNAs were synthesized from
the cRNAs, fragmented and endo-labeled. The sample
preparation, hybridizations to the microarrays, detection
and data analysis were performed by KURABO using a
GeneChip Exon Array (Human Exon 1.0 ST Array).
Primer extension analysis
Reverse transcription (RT) was performed using
SuperScript II reverse Transcriptase (Invitrogen). For
each reaction, cleaved or uncleaved RNAs were used
as templates. The primers were [
32P]-labeled with
Figure 3. Mapping of the cleavage sites, and their secondary structure prediction. (A) Mapping of the IRE1a cleavage sites on each mRNA by
primer extension analysis. RNA fragments identiﬁed as cleavage targets in the in vitro cleavage assay (Supplementary Figure S5) were used as
templates for the primer extension analysis. The direct sequencing analysis of each mRNA is shown on the right side of each panel. Below the panels
are partial sequences containing the cleavage sites (indicated by arrows). (B) Conservation of the consensus sequence in the cleavage targets of
IRE1a. The sequences around the cleavage sites in ten cleavage targets of IRE1a are shown. The consensus sequence is indicated by the gray box. (C)
Schematic representation of the IRE1a cleavage sites with secondary structures. The secondary structures around the cleavage sites were predicted
using M-FOLD or CentroidFOLD. The cleavage sites identiﬁed in (A) are indicated by arrows.
6268 Nucleic Acids Research, 2010,Vol.38, No. 18MEGALABEL (Takara). The resulting products were
resolved on a sequencing gel [7M urea, 6% acrylamide
with Long Ranger Gel Solution (Takara)]. To map the
products onto each mRNA (Figure 3A), the same
radiolabeled primers were used to sequence the corres-
ponding cDNAs. For CD59 and XBP1, the previously
reported RNA fragments and cDNA templates were
used (18,24). Sequencing was carried out using the T7
Sequencing Kit (USB) or the SequiTherm EXCEL II
DNA Sequencing Kit (EPICENTRE Biotechnologies).
The sequencing reactions were run in lanes adjacent to
the primer extension reactions, and the resolved gels
were dried for autoradiography. The following primers
were used: CD59 (NM_203331), 50-GTGACGTCGTTG
AAATTGCAATGC-30; PPP2R1A (NM_014225), 50-GA
CGTCCACATCCTGGTCC-30; RUVBL1 (NM_003707),
50-CACACCAGGTAAGGAAGG-30; GEMIN5
(NM_015465), 50-ACACTTCTGATCAGATGAAG-30;
YWHAQ (NM_006826), 50-GTAAGGGAGGGAATGT
AG-30; PEPD (NM_000285), 50-CAATCTCTTCCACA
GTGCG-30; PDK2 (NM_002611), 50-GATGGACTAGG
CTTGTGG-30; MKRN2 (NM_014160), 50-GAGCTCAC
AACTTGAATGC-30; PRKCD (NM_006254), 50-GAAT
ATGTTCTCTTTGCACATCC-30; XBP1 (NM_005080),
50-GAATCTGAAGAGTCAATACC-30.
Prediction of cellular localization and secondary structure
of mRNAs
For Figure 3B, secondary structure was predicted
using M-FOLD (http://mobyle.pasteur.fr/cgi-bin/portal.
py?form=mfold) or CentroidFOLD (http://www.ncrna.
org/centroidfold/).
RESULTS
Development of the novel screening procedure
To identify mRNAs cleaved by IRE1a, we devised the
molecular screen shown in Figure 1A. In brief, total
RNA was isolated from cells and subjected to in vitro
cleavage by IRE1a (18,24). Then the RNAs were reverse
transcribed with an oligo-dT primer and treated with
RNase H, a ribonuclease which speciﬁcally degrades the
RNA strands of RNA–DNA hybrids. This treatment
removed the uncleaved RNAs and the 30 fragments from
the cleaved RNAs, because these RNAs would form
hybrids with their own cDNAs. The remaining 50 frag-
ments of the cleaved RNAs were puriﬁed to remove the
cDNA molecules. The sample containing these 50 RNA
fragments was used as a probe in the microarray
analysis. A mock-treated reference sample was prepared
in the same way but with GFP instead of IRE1a.
First, we checked the quality of IRE1a used for the
in vitro cleavage (Supplementary Figure S1). As the
XBP1, mRNA fragment was cleaved by wild-type
IRE1a, not by the mutant IRE1a (K599A) or
mock-treated, it was conﬁrmed that the cleavage
proceeds from IRE1a and not from a contaminating
RNase (Supplementary Figure S1).
Next, we checked whether the designed reaction could
be used to detect cleaved XBP1 mRNA. Total RNA was
incubated with IRE1a or GFP, and treated with or
without reverse transcriptase and RNaseH, and then
analyzed by northern blotting with a probe speciﬁc to
the 50 exon of XBP1 (Figure 1B). After treatment with
IRE1a, the mRNA was eﬃciently converted to a faster
migrating species, which corresponded to the cleaved 50
fragment (Figure 1B, left panel). The subsequent RT
reaction and RNase H treatment eliminated the signals
from the uncleaved mRNA in both the IRE1a-treated
and mock-treated samples. Only the 50 fragment of the
cleaved mRNA could be detected in the IRE1a-treated
sample (Figure 1B, right panel). These results indicated
that the designed reaction can eﬀectively produce
cleavage-speciﬁc fragments, and enables us to detect the
cleavage of XBP1 mRNA.
We also paid attention to choosing the appropriate
microarray (Figure 1A). Currently, there are several
popular types of expression microarrays, including 30,
whole Gene and Exon microarrays (Aﬀymetrix). The
30IVT array contains probes derived from the
30-terminus of each mRNA, and is the most widely used
expression array. However, this type of array is not
suitable for our study, because we need to detect the 50
fragments of cleaved RNAs. The Gene array contains
probes derived from the entire length of each mRNA,
and is designed to integrate all of the data for each gene.
Therefore, this array would not allow us to analyze indi-
vidual signals derived from probes for a single gene. The
Exon microarray is designed to analyze each exon separ-
ately, and therefore we adopted the Exon microarray for
our screen.
Screening for cleavage targets of IRE1a
The samples prepared from both the IRE1a-treated and
the mock-treated reactions described above were
hybridized to the Exon microarrays. More than 37000
exons gave signals that were at least 2-fold stronger in
the IRE1a-treated sample compared with the
mock-treated sample (data not shown). The well-known
target XBP1 was found among these exons and ranked
269th based on signal intensity. Thus, this screen
appeared to capture the cleavage targets of IRE1a,
including the previously identiﬁed target.
To select robust candidates from the enormous number
of the exons, exons fulﬁlling the following requirements
were identiﬁed: ranking within the top 300 based on signal
intensity in the IRE1a-treated sample; showing a
>2.5-fold higher signal in the IRE1a-treated sample
compared with the mock-treated sample; and being regis-
tered at NCBI. The resulting 56 genes were selected as
IRE1a cleavage candidates (Supplementary Table S1)
and were subjected to further analysis.
First, each cleavage candidate (Supplementary
Table S1) was evaluated by northern-blot analysis. Total
RNA samples were incubated with IRE1a or GFP and
analyzed using northern blots with a speciﬁc probe for
each candidate gene. We were able to detect 46 of the 56
mRNAs, and among them, 19 showed faster migrating
species after treatment with IRE1a (Figure 2A;
Supplementary Figure S2). Next, the cleavage of each
Nucleic Acids Research, 2010,Vol.38, No. 18 6269mRNA was further analyzed with puriﬁed RNA frag-
ments, not with total RNA, to conﬁrm that these candi-
dates are themselves cleaved by IRE1a. The cDNA of
each candidate gene was ampliﬁed by PCR as a set of
smaller, partially overlapping fragments, which were
subcloned and then transcribed in vitro to produce
isolated mRNA fragments. These were treated with and
without IRE1a (Supplementary Figure S3). This assay
revealed that 13 of the mRNAs were cleaved upon treat-
ment with IRE1a (Figure 2B; Supplementary Figure S3).
Thus, the screening method led us to identify 13 novel
targets that are cleaved by IRE1a in vitro (Table 1).
In order to verify that this screen was speciﬁc in iden-
tifying IRE1a cleavage targets, we further selected 20
genes whose exons exhibited ratios near 1.0 in the micro-
array analysis (Supplementary Table S3). These mRNAs
were tested for cleavage by IRE1a. Northern blotting with
speciﬁc probes allowed us to detect 14 of the 20 mRNAs
tested. Importantly, none of the 14 mRNAs showed faster
migrating species after treatment with the IRE1a
(Supplementary Figure S4). This indicated that the
mRNAs identiﬁed as non-candidates in the screening are
actually not cleaved by IRE1a. Thus, the screening
method was eﬀective in speciﬁcally identifying cleavage
targets of IRE1a.
Identiﬁcation of a consensus sequence in the cleavage
targets of IRE1a
The identiﬁcation of novel cleavage targets and the in vitro
technique allowed us to look for common characteristics
in the sequences cleaved by IRE1a. Therefore, we began
by mapping the novel cleavage sites as follows.
First, the newly identiﬁed RNAs (Table 1) were further
fragmented as described above and subjected to in vitro
cleavage (Supplementary Figure S5). This conﬁrmed that
all of the 13 mRNAs were cleaved, and allowed us to
identify smaller regions of 400–700nt that contained the
cleavage sites (indicated by red characters in
Supplementary Figure S5). Next, eight candidates
(PPP2R1A, GEMIN5, MKRN2, PRKCD, YWHAQ,
PEPD, PDK2 and RUVBL1) were selected based on the
cleavage eﬃciency in Supplementary Figure S5, and sub-
jected to RT-driven primer extension to map the cleavage
sites (Figure 3A). While most of the mRNAs (PPP2R1A,
GEMIN5, MKRN2, PRKCD, YWHAQ, PEPD and
PDK2) contained one cleavage site, the RUVBL1
mRNA contained two cleavage sites located close to
each other (Figure 3A). In the primer extensions, some
of the mRNAs showed a 1-bp shifted band in addition
to the major primer extension signal (see the IRE1a-
treated lanes in Figure 3A). This was likely caused by an
accidental shortening or partial degradation after the
IRE1a cleavage.
Surprisingly, this mapping identiﬁed a consensus
sequence that was common to all the cleavage sites. Of
the nine newly identiﬁed sites, six [in mRNAs PPPR1A,
RUVBL1 (1559/1560), GEMIN5, PRKCD, PEPD and
PDK2] were located in the consensus sequence CUGC
AG, and the remaining three sites [in RUVBL1 (1535/
1536), MKRN2 and YWHAQ] were in sequences that dif-
fered by only one base from the consensus (Figure 3B).
Also, all of the cleavage sites were positioned between the
second and third base in the consensus (Figure 3B).
Moreover, stem-loop structures were predicted to accom-
pany the sites, and the cleavage sites were located in the
loop portion (Figure 3C), which is similar to a stem-loop
structure in XBP1 (13,14).
The consensus sequence was also found in the known
targets of IRE1a. As shown in Figure 4A, the cleavage site
on CD59 occurs in the CUGCAG consensus. Two
cleavage sites were mapped in XBP1 by primer extension,
one between the second and third bases in the consensus
565CUGCAG
570, and one between the second and third
bases in
539CCGCAG
544 (Figure 4B). These mapped pos-
itions in XBP1 were shifted by 1bp from those suggested
Table 1. The newly identiﬁed cleavage targets of IRE1a
Accession
number
Size (bp) Gene ER-targeting
signal (in protein)
a
Cellular
localization
(of protein)
b
mRNA
region
containing
the cleavage site
c
Position of
cleavage site
d
NM_014225 2357 PPP2R1A – Cytoplasm 1336–1919 1747/1748
NM_003707 1750 RUVBL1 – Cytoplasm 1290–1675 1535/1536, 1559/1560
NM_001008883 2093 CCT3 – Cytoplasm 1249–1685 –
NM_015465 5399 GEMIN5 – Nuclear or cytoplasm 4660–5349 4860/4861
NM_001025242 3499 IRAK1 – Nuclear 1617–2364 –
NM_014160 2778 MKRN2 – Nuclear 2088–2710 2250/2251
NM_006254 2850 PRKCD – Cytoplasm 1337–1989 1735/1736
NM_016098 988 BRP44L – Cytoplasm 471–905 –
NM_004462 2155 FDFT1 – Cytoplasm 632–1265 –
NM_007221 1082 PMF1 – Nuclear or cytoplasm 405–1082 –
NM_006826 2166 YWHAQ – Nuclear 858–1392 1167/1168
NM_000285 2018 PEPD – Cytoplasm 1242–1596 1454/1455
NM_002611 2319 PDK2 – Cytoplasm 1802–2149 1977/1978
aThe presence of an ER-targeting signal in the translated protein was predicted using SignalP 3.0 (http://www.cbs.dtu.dk/services/SignalP/).
bThe cellular localization of the translated protein was predicted using PSORT II (http://psort.ims.u-tokyo.ac.jp/form2.html).
cThe mRNA region containing the cleavage site is based on the data in Supplementry Figure S5.
dThe position of the cleavage site was evaluated based on the data in Figure 3A.
6270 Nucleic Acids Research, 2010,Vol.38, No. 18in the previous reports (13,14). However, the sequence
of the spliced XBP1 mRNA is thought to be identical in
either case because both of the sites were shifted equally.
The 1-bp shift of the cleavage sites would not be an artifact
caused by the use of cytosolic domain of IRE1a, because
the full-length IRE1a also cleaved XBP1 mRNA at
the identical positions (Supplementary Figure S6).
The substitution of the G at the third position of the
consensus with a C (G567C) in XBP1 (13) speciﬁcally
eliminated cleavage at the 566/567 point (Figure 4B).
The G in the third position is strictly conserved among
all the targets (Figure 3B), therefore, this residue
may be one of the determinants of speciﬁc cleavage by
IRE1a.
DISCUSSION
In this study, we devised a genome-wide screening method
to identify cleavage targets of IRE1a (Figure 1), and
identiﬁed 13 novel targets (Table 1) that are cleaved
in vitro by IRE1a (Figure 2; Supplementary Figures S2,
S3 and S5). Moreover, an analysis of the novel cleavage
sites resulted in the identiﬁcation of a consensus sequence
(CUGCAG), which is accompanied by a stem-loop struc-
ture (Figure 3). The consensus sequence and structure are
also conserved in the previously identiﬁed IRE1a targets,
CD59 and XBP1 (Figure 4). This is the ﬁrst report iden-
tifying a consensus element that is recognized and cleaved
by IRE1a, based on a comparison analysis with multiple
targets.
The constructed screening method was useful in the case
of IRE1a. However, there is room for some improve-
ments. One improvement would be to eliminate the
possible 30 bias in the identiﬁed cleavage sites. In this
screening, most of the newly identiﬁed cleavage sites
were located within 1000bp of the mRNA 30 termini
(Figure 3; Supplementary Figure S5). It is unlikely that
such a bias would be seen in cells. For example, the
cleavage sites in XBP1 and CD59 are located in the middle
or the 50 ends of their mRNAs, respectively. One likely
reason for this artiﬁcial bias is the limitation in the length
of cDNA that can be transcribed in vitro by reverse tran-
scriptase under normal circumstances. Any regions of the
mRNA that are not reverse transcribed, such as regions
far from the poly-A tail, would remain undigested by the
RNase H in both the IRE1a-treated and mock-treated
samples. These would not be identiﬁed as possible
cleavage targets in the Exon microarray analysis. To
identify a wider range of targets, this problem should be
resolved in some way. Nevertheless, the screening method
has important advantages. One advantage is its versatility,
as the method could be adopted for use with any other
site-speciﬁc RNase that has an in vitro reaction. Moreover,
this method enables us to search the RNase-targets more
directly than the other approaches, as previous methods
including the proﬁling of cellular transcripts detect
many byproducts from various side eﬀects as well as the
inherent targets. With these advantages, the screening
method has the potential to be a useful tool in the RNA
research ﬁeld.
The most important point in this study is the identiﬁca-
tion of the consensus element recognized and cleaved by
IRE1a. The sequential and structural characters
(Figure 3), which is also found in the XBP1 and the
CD59 (Figure 4), are further conserved in other
IRE1a-targets, including mammalian IRE1  mRNA
itself (186/187 position) (23) or insulin mRNA (mIns2
site1) (25). Thus, the CUGCAG sequence and the
stem-loop structure seem to be highly conserved among
mammalian IRE1a-targets.
Recently, it was suggested that IRE1a-mediated RNA
processing is divided into two pathways, one is the clas-
sical pathway represented by the XBP1, and the other is
RIDD (regulated IRE1-dependent decay) (26). The
former pathway requires only the activation of IRE1a’s
RNase activity (26), and could be reconstituted in vitro
only with the activated RNase and target RNA. Because
the XBP1 mRNA (18), CD59 mRNA (24), insulin mRNA
(25) and the newly identiﬁed targets in this study
(Figure 3) were cleaved only with IRE1a in vitro, these
Figure 4. Conservation of the consensus sequence in the cleavage
targets of IRE1a.( A) Mapping of the IRE1a cleavage site in the
CD59 mRNA. A CD54 mRNA fragment was prepared and treated
with or without IRE1a as described in a previous report (24), and
used as a template for primer extension analysis. The direct sequencing
analysis of the mRNA is shown on the right side of the gel. A partial
sequence of the CD59 mRNA, including the cleavage site (indicated by
an arrow) is shown on the right. (B) Mapping of the IRE1a cleavage
sites in the XBP1 mRNA. XBP1 mRNA fragments were treated with
or without IRE1a as described in a previous report (18), and used as
templates for primer extension analysis. The direct sequencing analysis
of the XBP1 mRNA is shown on the right side of each gel. Partial
sequences of the XBP1 mRNA, including the cleavage sites (indicated
by arrows), are shown to the right. The substituted residue (G567C) is
indicated by a gray box.
Nucleic Acids Research, 2010,Vol.38, No. 18 6271mRNAs would be processed by the classical pathway.
Similarly, the consensus element (CUGCAG sequence
accompanied with the stem-loop structure) would be ap-
plicable to this pathway. Meanwhile, in the RIDD
pathway that targets BLOS1 or SCARA3 mRNA in
mammal (26), any consensus sequence or structural char-
acters have not been identiﬁed. One reason behind this is
that RIDD pathway would need some other factors than
IRE1 RNase to process target RNA (26), and detailed
analysis including the identiﬁcation of the cleavage sites
have not been performed. Therefore, it is unclear that the
consensus element in the classical pathway is common in
the RIDD pathway.
As mentioned in the ‘Introduction’ section,
post-transcriptional gene regulation mediated by the
IRE1 proteins has received a lot of attention, and
various targets have been identiﬁed. Most of the
cleavage targets of the mammalian IRE1a, other than
XBP1, are rapidly degraded upon ER stress (24–27).
Thus, we wondered whether the newly identiﬁed
mRNAs (Table 1) also show stress-dependent decay. In
particular, since the RUVBL1 mRNA contains two
cleavage sites (Figure 3A), this transcript might be pro-
cessed similarly to XBP1 with a size shift. To investigate
the former possibility, we performed a northern-blot
analysis of total RNA from stressed cells. However, no
stress-dependent decay was detected in any of the 13
newly identiﬁed mRNAs (Supplementary Figure S7).
Furthermore, no size sifting was detected in RT-PCR
analyses of the 13 mRNAs, even after stress conditions
(data not shown). Therefore, it is highly possible that
these mRNAs are not cleaved in cells, even though they
are cleaved in vitro. The putative lack of cleavage in cells
may be explained by cellular localization. Indeed, a
previous report indicated that the localization of the
target mRNA to the ER membrane is an important
factor in stress-dependent decay by IRE1a (22).
Moreover, it was recently reported that the mammalian
XBP1 mRNA is tethered to the ER-membrane via nascent
peptides, and this tethering is important for eﬀective pro-
cessing (17). None of the newly identiﬁed IRE1a targets
has an ER-targeting signal or a signal peptide for secretion
or membrane localization (Table 1), and none of them
seem to be tethered to the ER-membrane. Thus, the dif-
ferent localization between IRE1a and the candidate
mRNAs may mean that these mRNAs are never cleaved
in cells.
However, it is still unclear whether these candidates
do not have any function under stressed conditions, as
any linkage of those contained genes with ER stress
response have not been studied. Moreover, there are still
many cellular IRE1a-targets as implied by a number of
recent studies (25,26). To identify these mRNAs, we will
need to reﬁne this screening method, or use mRNAs
isolated from various cells or tissues such as the
placenta, where the IRE1a pathway is signiﬁcantly
activated (29). As an alternative, an in silico approach
based on the consensus sequence (CUGCAG) might be
useful. Further research would be needed to address
these problems.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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